线粒体双链RNA积累在大脑衰老和阿尔茨海默病中的作用
bioRxiv : the preprint server for biology
|February 12, 2026
概括
线粒体双链RNA (mt-dsRNA) 随着衰老和阿尔茨海默病而积累,导致炎症和神经退行. 这项研究确定mt-dsRNA是大脑衰老和AD病变的关键因素.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 线粒体和炎症在衰老和阿尔茨海默病 (AD) 中密切相关.
- 线粒体双链RNA (mt-dsRNA) 是一种可疑的炎症触发物.
- 了解mt-dsRNA的作用对于神经退行性疾病研究至关重要.
研究的目的:
- 研究mt-dsRNA积累及其在老化和AD大脑中的信号通路.
- 为了将mt-dsRNA水平与认知衰退和神经病理学相关联.
- 探索线粒体RNA稳态与神经退行之间的联系.
主要方法:
- 对人类大脑组织和体外转录学数据集的分析.
- 量化线粒体转录和dSRNA编辑.
- 对dsRNA抗病毒信号蛋白和RNA处理机械的评估.
主要成果:
- 在中年之后mt-dsRNA的积累增加,在AD大脑中进一步升高.
- 增加的mt-dsRNA与认知障碍,疾病严重程度和AD风险基因型相关.
- 减少线粒体RNA处理和增加抗病毒信号表明mt-dsRNA驱动的炎症.
结论:
- 由mt-dsRNA积累标志着线粒体RNA稳定性破坏,有助于与年龄和AD相关的神经退行.
- mt-dsRNA作为老化大脑中慢性炎症的潜在驱动因素.
- 准mt-dsRNA通路可能为AD提供新的治疗策略.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


